ZYMEWORKS INC (ZYME:NASDAQ)
$28.86 -0.04 (-0.1384%)
Analysed ZYMEWORKS INC (ZYME:NASDAQ) News Sources
Zymeworks (ZYME) Could Be 39% Undervalued On 2026 Revenue Guidance And CIO Hire
09-10-2026
yahoo.com
Zymeworks Announces Participation in Upcoming Investor Conferences and Date of Third Quarter 2026 Financial Results
15-10-2026
yahoo.com
Zymeworks Appoints Suzanne Monahan as Senior Vice President, Commercial and General Manager, Theravance Biopharma
19-10-2026
yahoo.com
Zymeworks Enters into an Exclusive Global License and Collaboration Agreement with Roche for ZW209, a Trispecific T cell Engager Targeting DLL3
23-10-2026
yahoo.com
Zymeworks Signs Roche Deal with $55 Million Upfront, Up to $718 Million in Milestones
23-10-2026
yahoo.com
Zymeworks stock surges on $813M Roche licensing deal
23-10-2026
yahoo.com
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate ZW191 at ESMO Congress 2026
24-10-2026
yahoo.com
Faeth Appoints Adam Schayowitz, Ph.D., MBA, Head of Research and Development at Zymeworks, to Board of Directors
27-10-2026
yahoo.com
Zymeworks Highlights ZW191 Ovarian Cancer Responses, Roche Deal Upside
27-10-2026
marketbeat.com
Zymeworks Inc. (ZYME) to Report Q3 Results: Wall Street Expects Earnings Growth
29-10-2026
yahoo.com
What is the current price of ZYMEWORKS INC (ZYME:NASDAQ)?
The current price of ZYMEWORKS INC (ZYME:NASDAQ) is $28.86.
ZYMEWORKS INC (ZYME:NASDAQ) absolute price change since previous trading day?
The absolute price change of ZYMEWORKS INC (ZYME:NASDAQ) since the previous trading day is $-0.04.
ZYMEWORKS INC (ZYME:NASDAQ) percentage price change since previous trading day?
The percentage price change of ZYMEWORKS INC (ZYME:NASDAQ) since the previous trading day is -0.1384%.
What is the most recent average sentiment score for ZYMEWORKS INC (ZYME:NASDAQ)?
The most recent average sentiment score for ZYMEWORKS INC (ZYME:NASDAQ) is 80 out of 100.
What is the most recent average sentiment for ZYMEWORKS INC (ZYME:NASDAQ)?
The most recent sentiment for ZYMEWORKS INC (ZYME:NASDAQ) is .
SEC-8K** Filing Available For ZYMEWORKS INC (ZYME:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.